Cashman Neil

Chief Scientific Officer, DirectorProMIS Neurosciences Inc. (PMN) · full profile →Form 4 · filed Sep 24, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 22, 2025Grant(A)165K$0165K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001927064-25-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly: